INT206081

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.11
First Reported 2007
Last Reported 2007
Negated 0
Speculated 0
Reported most in Body
Documents 1
Total Number 1
Disease Relevance 0.81
Pain Relevance 0.17

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

extracellular space (IL6ST, IL6) extracellular region (IL6ST, IL6) aging (IL6)
plasma membrane (IL6ST)
IL6ST (Homo sapiens)
IL6 (Homo sapiens)
Pain Link Frequency Relevance Heat
Inflammation 54 79.32 Quite High
Arthritis 10 69.28 Quite High
cytokine 27 59.28 Quite High
Inflammatory response 8 5.00 Very Low Very Low Very Low
Inflammatory marker 3 5.00 Very Low Very Low Very Low
Pain 3 5.00 Very Low Very Low Very Low
tolerance 3 5.00 Very Low Very Low Very Low
chemokine 3 5.00 Very Low Very Low Very Low
alcohol 2 5.00 Very Low Very Low Very Low
Inflammatory mediators 2 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
INFLAMMATION 68 79.32 Quite High
Cancer 18 69.72 Quite High
Arthritis 10 69.28 Quite High
Dementia 8 68.16 Quite High
Diabetes Mellitus 33 67.76 Quite High
Osteoporosis 35 67.08 Quite High
Cardiovascular Disease 20 66.52 Quite High
Increased Venous Pressure Under Development 6 65.52 Quite High
Atherosclerosis 44 64.36 Quite High
Aging 21 62.28 Quite High

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Newer drugs will include interleukin-6 inhibitor/antibody, interleukin-6 receptor inhibitor/antibody, interleukin-6 antisense oligonucleotide (ASON), gp130 protein inhibitor/antibody, tyrosine kinases inhibitors/antibodies, serine/threonine kinases inhibitors/antibodies, mitogen-activated protein (MAP) kinase inhibitors/antibodies, phosphatidylinositol 3-kinase (PI3K) inhibitors/antibodies, Nuclear factor ?
gp130 Negative_regulation (inhibitor/antibody) of interleukin-6
1) Confidence 0.11 Published 2007 Journal Immun Ageing Section Body Doc Link PMC1845171 Disease Relevance 0.81 Pain Relevance 0.17

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox